Mitochondria have both a pro-neuronal growth and pro-neuronal death role during a stroke. On the one hand, mitochondria generate ATP to maintain normal neuronal function, on the other hand, mitochondria generate reactive oxygen species (ROS), causing oxidative stress-induced neuronal damage. Although mitochondria have been relatively well studied during a stroke attack, lots of mysteries remain unsolved. Ace Therapeutics provides a full service to explore the mechanisms of mitochondrial action during the stroke attack from the perspectives of oxidative stress, mitophagy, and mitochondria-dependent apoptosis.
Mitochondria are the main source of ROS production. Given that after an ischemic stroke attack, mitochondria produce large amounts of ROS, and ROS can destroy lipids, proteins, and nucleic acids in cells and also trigger multiple molecular signaling pathways to further worsen stroke, Ace Therapeutics established in vitro and in vivo stroke models and related assay services to investigate the effects of ROS on the pathological process of stroke, including but not limited to
The role of mitophagy in stroke has not been well disclosed. For this reason, Ace Therapeutics offers a comprehensive exploration service to disclose the role of mitophagy in stroke.
In addition to being a source of cellular power, mitochondria are closely associated with many apoptosis-related proteins, such as the B-cell lymphoma (Bcl-2) family and apoptosis-inducing factors. For this function, Ace Therapeutics offers assays for pro-apoptotic factors such as Bax, Bak, cytochrome c, and nuclear endonuclease G, and anti-apoptotic factors such as Bcl-2, Bcl-xL, and Bcl-w.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.